Involvement of Nrf2 in proteasome inhibition-mediated induction of ORP150 in thyroid cancer cells

Oncotarget

Volumn 7, Issue 3, 2016, Pages 3416-3426

  Zong, Zhi Hong ^a   Du, Zhen Xian ^a   Zhang, Hai Yan ^a   Li, Chao ^a   An, Ming Xin ^a   Li, Si ^a   Yao, Han Bing ^a   Wang, Hua Qin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Nrf2; ORP150; Proteasome inhibitor; Thyroid cancer

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MESSENGER RNA; OXYGEN REGULATED PROTEIN 150; PROTEASOME; TRANSCRIPTION FACTOR NRF2; HEAT SHOCK PROTEIN 70; NFE2L2 PROTEIN, HUMAN; OXYGEN-REGULATED PROTEINS; PROTEASOME INHIBITOR; SMALL INTERFERING RNA;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NRF2 GENE; ORP150 GENE; PROMOTER REGION; PROTEIN EXPRESSION; THYROID CANCER CELL LINE; TRANSACTIVATION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; NF-E2-RELATED FACTOR 2; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 84962311263     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6636     Document Type: Article

References (33)

1. Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer. 2004; 4:349-360.
2. Aleshin AN, Sawa Y, Kitagawa-Sakakida S, Bando Y, Ono M, Memon IA, Tohyama M, Ogawa S, Matsuda H. 150-kDa oxygen-regulated protein attenuates myocardial ischemia-reperfusion injury in rat heart. J Mol Cell Cardiol. 2005; 38:517-525.
3. Asahi H, Koshida K, Hori O, Ogawa S, Namiki M. Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. BJU Int. 2002; 90:462-466.
4. Bando Y, Tsukamoto Y, Katayama T, Ozawa K, Kitao Y, Hori O, Stern DM, Yamauchi A, Ogawa S. ORP150/HSP12A protects renal tubular epithelium from ischemiainduced cell death. Faseb J. 2004; 18:1401-1403.
5. Chen J, Xiong J, Liu H, Chernenko G, Tang SC. Distinct BAG-1 isoforms have different anti-apoptotic functions in BAG-1-transfected C33A human cervical carcinoma cell line. Oncogene. 2002; 21:7050-7059.
6. Du ZX, Yan Y, Zhang HY, Liu BQ, Gao YY, Niu XF, Meng X, Wang HQ. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells. J Clin Endocrinol Metab. 2011; 96: E763-771.
7. Fribley A, Zeng Q, Wang CY. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol. 2004; 24:9695-9704.
8. Gao YY, Liu BQ, Du ZX, Zhang HY, Niu XF, Wang HQ. Implication of oxygen-regulated protein 150 (ORP150) in apoptosis induced by proteasome inhibitors in human thyroid cancer cells. J Clin Endocrinol Metab. 2010; 95:E319-326.
9. Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem. 2005; 280:29158-29168.
10. Kaneda S, Yura T, Yanagi H. Production of three distinct mRNAs of 150 kDa oxygen-regulated protein (ORP150) by alternative promoters: preferential induction of one species under stress conditions. J Biochem. 2000; 128:529-538.
11. Kim R, Emi M, Tanabe K, Murakami S. Role of the unfolded protein response in cell death. Apoptosis. 2006; 11:5-13.
12. Kitano H, Nishimura H, Tachibana H, Yoshikawa H, Matsuyama T. ORP150 ameliorates ischemia/reperfusion injury from middle cerebral artery occlusion in mouse brain. Brain Res. 2004; 1015:122-128.
13. Kitao Y, Ozawa K, Miyazaki M, Tamatani M, Kobayashi T, Yanagi H, Okabe M, Ikawa M, Yamashima T, Stern DM, Hori O, Ogawa S. Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity. J Clin Invest. 2001; 108:1439-1450.
14. Kitao Y, Hashimoto K, Matsuyama T, Iso H, Tamatani T, Hori O, Stern DM, Kano M, Ozawa K, Ogawa S. ORP150/HSP12A regulates Purkinje cell survival: a role for endoplasmic reticulum stress in cerebellar development. J Neurosci. 2004; 24:1486-1496.
15. Li S, Zhang HY, Wang T, Meng X, Zong ZH, Kong DH, Wang HQ, Du ZX. BAG3 promoted starvation-induced apoptosis of thyroid cancer cells via attenuation of autophagy. J Clin Endocrinol Metab. 2014; 99:E2298-2307.
16. Luo S, Baumeister P, Yang S, Abcouwer SF, Lee AS. Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements. J Biol Chem. 2003; 278:37375-37385.
17. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007; 9:2277-2293.
18. Matsushita K, Matsuyama T, Nishimura H, Takaoka T, Kuwabara K, Tsukamoto Y, Sugita M, Ogawa S. Marked, sustained expression of a novel 150-kDa oxygen-regulated stress protein, in severely ischemic mouse neurons. Brain Res Mol Brain Res. 1998; 60:98-106.
19. Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D, Neckers L. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther. 2004; 3:551-566.
20. Miyagi T, Hori O, Koshida K, Egawa M, Kato H, Kitagawa Y, Ozawa K, Ogawa S, Namiki M. Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells. Int J Urol. 2002; 9:577-585.
21. Miyazaki M, Ozawa K, Hori O, Kitao Y, Matsushita K, Ogawa S, Matsuyama T. Expression of 150-kd oxygenregulated protein in the hippocampus suppresses delayed neuronal cell death. J Cereb Blood Flow Metab. 2002; 22: 979-987.
22. Namba T, Hoshino T, Tanaka K, Tsutsumi S, Ishihara T, Mima S, Suzuki K, Ogawa S, Mizushima T. Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells. Mol Pharmacol. 2007; 71:860-870.
23. Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Dunner K, Jr., Huang P, Abbruzzese JL, McConkey DJ. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res. 2005; 65:11658-11666.
24. Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Jr., Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006; 107:4907-4916.
25. Ozawa K, Kuwabara K, Tamatani M, Takatsuji K, Tsukamoto Y, Kaneda S, Yanagi H, Stern DM, Eguchi Y, Tsujimoto Y, Ogawa S, Tohyama M. 150-kDa oxygenregulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J Biol Chem. 1999; 274:6397-6404.
26. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008; 93:4331-4341.
27. Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE, Moroni M. HYOU1/Orp150 expression in breast cancer. Med Sci Monit. 2007; 13:BR231-239.
28. Tamatani M, Matsuyama T, Yamaguchi A, Mitsuda N, Tsukamoto Y, Taniguchi M, Che YH, Ozawa K, Hori O, Nishimura H, Yamashita A, Okabe M, Yanagi H et al. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med. 2001; 7:317-323.
29. Tsukamoto Y, Kuwabara K, Hirota S, Kawano K, Yoshikawa K, Ozawa K, Kobayashi T, Yanagi H, Stern DM, Tohyama M, Kitamura Y, Ogawa S. Expression of the 150-kd oxygen-regulated protein in human breast cancer. Lab Invest. 1998; 78:699-706.
30. Wang HQ, Du ZX, Zhang HY, Gao DX. Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells. Endocrinology. 2007; 148:3258-3270.
31. Wang HQ, Liu BQ, Gao YY, Meng X, Guan Y, Zhang HY, Du ZX. Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br J Pharmacol. 2009; 158:1405-1412.
32. Yoshida H, Okada T, Haze K, Yanagi H, Yura T, Negishi M, Mori K. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol. 2000; 20:6755-6767.
33. Zong ZH, Du ZX, Li N, Li C, Zhang Q, Liu BQ, Guan Y, Wang HQ. Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells. Biochim Biophys Acta. 2012; 1823:1395-1404.